It. Uzbay et al., EFFECTS OF BROMOCRIPTINE AND HALOPERIDOL ON ETHANOL WITHDRAWAL SYNDROME IN RATS, Pharmacology, biochemistry and behavior, 49(4), 1994, pp. 969-974
The effects of bromocriptine and haloperidol, either alone or in combi
nation, on ethanol withdrawal syndrome (EWS) have been investigated in
rats. Bromocriptine (5 mg/kg IP) inhibited wet dog shakes behavior an
d catatonia but potentiated the intensity of abnormal gait. The latenc
y of the audiogenic seizures was prolonged by bromocriptine treatment.
Haloperidol (0.5 mg/kg SC) decreased the intensity of stereotyped beh
avior but potentiated catatonia and agitation. It did not antagonize t
he behaviors induced by bromocriptine when injected in combination exc
ept the increased latency of the audiogenic seizures. The total intens
ity score of the EWS was not significantly different from that in untr
eated control. The results suggest that brain dopaminergic system may
be involved to a limited extent in mediating the EWS in rats.